OMERACT Patient Research Partner Network
  • Home
  • About Us
  • New PRPs
  • Resources
  • Webinars
  • Membership
  • Gallery
  • FAQ
  • More
    • Home
    • About Us
    • New PRPs
    • Resources
    • Webinars
    • Membership
    • Gallery
    • FAQ
OMERACT Patient Research Partner Network
  • Home
  • About Us
  • New PRPs
  • Resources
  • Webinars
  • Membership
  • Gallery
  • FAQ

Webinars

General introduction about objectives and methodology of OMERACT

General introduction about objectives and methodology of OMERACT

General introduction about objectives and methodology of OMERACT

  

a) Understand how patient research partners can contribute to the development of a core outcome set. 

b) Understand the three key components of the original OMERACT filter: truth, discrimination and feasibility.

c) Recognize the different forms of validity that are important from the perspective of patients: truth and feasibility.

d) Contr

  

a) Understand how patient research partners can contribute to the development of a core outcome set. 

b) Understand the three key components of the original OMERACT filter: truth, discrimination and feasibility.

c) Recognize the different forms of validity that are important from the perspective of patients: truth and feasibility.

d) Contribute actively to the critical appraisal of measurement instruments. 

Watch Here

Communication and collaboration in OMERACT working groups

General introduction about objectives and methodology of OMERACT

General introduction about objectives and methodology of OMERACT

  

a) Integration into Working Groups

b) The OMERACT recommendations for involvement of PRPs in working groups.

c) Do’s and don’ts for communication between researchers and PRPs 

watch here

Introduction to an OMERACT Conference

General introduction about objectives and methodology of OMERACT

Introduction to an OMERACT Conference

  

a) The OMERACT consensus process

b) The workshops and sigs;

c) Meeting structure and program

d) Voting

e) General Questions & Discussion 

Watch here

Place of Patients in the Regulatory Process

An Introduction to OMERACT and Core Outcome Set Development in Rheumatology

OMERACT and Patient involvement in core domain set development

a) OMERACT and the regulatory process 

b) Why is PRP involvement in the regulatory process important? 

c) The FDA strategy for patient involvement 

d) The EMA strategy for patient involvement 

e) What is the difference between a patient research partner (PRP) and a patient advocate?

Watch Here

OMERACT and Patient involvement in core domain set development

An Introduction to OMERACT and Core Outcome Set Development in Rheumatology

OMERACT and Patient involvement in core domain set development

a) Povide a general introduction inthe OMERACT way of developing a Core Domain Set. 

b) Introduce the importance of patientinvolvement in Core Domain Set development.  

c) Explain the role and experiences ofpatient research partners in the OMERACT working group for Myositis.

Watch Here

An Introduction to OMERACT and Core Outcome Set Development in Rheumatology

An Introduction to OMERACT and Core Outcome Set Development in Rheumatology

An Introduction to OMERACT and Core Outcome Set Development in Rheumatology

 

a) Provide a general introduction in the Delphi Method

b) Understand the placeand purpose of the Delphi Method in the context of Core Domain Set development

c) Learn how you as a patient research partner (PRP) can contribute to the design and conduct of a Delphi study.

Download Here

Copyright © 2022 OMERACT Patient Research Partner Network - All Rights Reserved.

Powered by GoDaddy